Lv1
10 积分 2026-07-28 加入
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases
8小时前
已完结
Effectiveness and safety of efgartigimod in myasthenia gravis: A meta-analysis of different antibody subtypes
2个月前
已完结
The efficacy and safety of FcRn inhibitors in patients with myasthenia gravis: a systematic review and meta-analysis
2个月前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
